ETHZilla

ETHZilla Current Ratio

The Current Ratio of ETHZilla (ETHZ) as of Oct 17, 2026 is 0.33. In the previous year, Current Ratio was 1.16 — a change of -71.45% (lower).

Current Ratio

0.33

YoY

-71.45%

Last updated:

Current Ratio of ETHZilla is 2025 0.33 . Current Ratio of ETHZilla was 2024 1.16 . It decreases by -71.45% lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

ETHZilla Stock analysis

What does ETHZilla do? ETHZilla Corp, based in New York City, operates in the Health Care sector within Biotechnology. The company develops pharmaceuticals for chronic pain and inflammatory diseases, focusing on three research programs: Fibrosis and Anti-TNF targeting conditions like Dupuytren’s contracture and NASH; SCAs addressing chronic pain and early arthritis; and a7nAChR for smoking cessation and ulcerative colitis. Listed on 27 June 2017, ETHZilla Corp employs four full-time staff. ETHZilla is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ETHZilla stock

Current Ratio of ETHZilla is 0.33 in 2025.

Current Ratio of ETHZilla changed from 1.16 to 0.33, representing a -71.45% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Ratio ETHZilla since 2006 – with annual values, charts, and detailed analysis.

The Current Ratio measures a company's ability to pay short-term obligations. A ratio above 1 indicates that current assets exceed current liabilities.

Current Ratio = Current Assets / Current Liabilities

A 'good' varies by industry and company stage. On Eulerpool, you can compare Current Ratio's ETHZilla with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — ETHZilla

All Key Metrics — ETHZilla